Asier Antoranz Martinez

5PUBLICATIONS
83CO-AUTHORS
Medical infection agents (incl. prions)Tumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 18, 2026
Integrated multi-omics identifies distinct macrophage alterations during progression of metabolic dysfunction-associated steatohepatitis.

|Jun 18, 2025
Cytotoxic NK Cells Impede Response to Checkpoint Immunotherapy in Melanoma with an Immune-Excluded Phenotype.

Joanna Pozniak, Niccolò Roda, Ewout Landeloos

|Jun 06, 2024
Nucleotide metabolism in cancer cells fuels a UDP-driven macrophage cross-talk, promoting immunosuppression and immunotherapy resistance.

Tommaso Scolaro, Marta Manco, Mathieu Pecqueux

|Apr 12, 2023
Multiomics and spatial mapping characterizes human CD8+ T cell states in cancer.

Stefan Naulaerts, Angeliki Datsi, Daniel M Borras

|Jul 14, 2022
Mapping the Immune Landscape in Metastatic Melanoma Reveals Localized Cell-Cell Interactions That Predict Immunotherapy Response.

Asier Antoranz, Yannick Van Herck, Maddalena M Bolognesi

Pageof 1

Frequent Collaborators

4 joint publications

Francesca M Bosisio

3 joint publications

Frederik De Smet

3 joint publications

Oliver Bechter

3 joint publications

Diether Lambrechts